You are currently viewing a new version of our website. To view the old version click .

Cancer Treatment: New Drugs and Strategies

This special issue belongs to the section “Molecular Oncology“.

Special Issue Information

Dear Colleagues,

Cancer is recognized by many as a serious global health problem and its possible treatment is a daily and highly complex challenge. Numerous advances have been made in surgery, chemotherapy, radiotherapy or even the use of nanoparticles. However, the field of oncological medicine needs more answers, and recent advances are nothing more than the beginning of new discoveries. Nanomedicines, combined therapy, drug repurposing, genomics or personalized therapy can open up other areas of interest for innovative formulations in the fight against cancer. This Special Issue intends to address and present studies that may touch on several of the areas mentioned, but that have the purpose of presenting new strategies that incorporate pharmacologically important drugs or even using strategies that stand out from those currently in use. Examples of these strategics include in silico studies, data treatment or studies of translation. New strategies should potentially inhibit the growth and spread of specific cancer cells, and ultimately cause reduced damage to healthy cells. Studies that show the feasibility of transforming the immune system and keeping it safe against tumor cells are equally important for this Special Issue.

Prof. Dr. Nuno Vale
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer therapy
  • new drug conjugates
  • drug delivery
  • drug combinations
  • precision medicine
  • in silico strategies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Int. J. Mol. Sci. - ISSN 1422-0067